ARCHIVES

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

This article is from The Cancer Letter archive.

Vol. 40 No. 34 | September 12, 2014

Download PDF Visit The Full Archive

Related Articles

Surgery Lowers Risk By 90% In Women With Gene Mutations

April 30, 2004

DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy

May 27, 1988

Abstracts Of “Most Newsworthy” Papers At AACR Meeting

May 27, 1977

Obey Surprises Everyone, Including Himself, And Plugs For More Money For NCI, NHLBI

March 7, 1980

Supplements Reduce Deaths In NCI Studies In China “JNCI”

September 17, 1993

Letter: Headline Criticized On Letter About Consortium

June 21, 1996